Meet Replior at OCT Nordics 2026
De-risk clinical trials with better data, better engagement and better study design.
Join Replior at Outsourcing in Clinical Trials Nordics in Copenhagen and discover how our integrated eClinical platform brings together EDC, behavioural-science eCOA and clinical-grade sensors to help sponsors and CROs reduce operational risk and improve data quality.
- October 20-21, 2026
- Copenhagen, Denmark
- Booth 48
About OCT Nordics
OCT Nordics brings together pharmaceutical, biotechnology and medical device professionals to discuss strategies for operational success in clinical trials.
The 2026 event combines clinical operations and clinical trial supply, with 400+ attendees, 30+ exhibitors and 30+ speakers, creating a focused setting for sponsors, CROs and technology partners to exchange ideas, build partnerships and explore the latest developments in trial delivery.
Discover what we’re bringing to the event
Replior EDC
Model the study, not the forms.
Most EDCs start with the CRF and layer study logic on top. Replior starts with the protocol.
Visit schedules, event branches and conditional pathways are part of the underlying study model, allowing data collection to follow the study rather than forcing the study into a form-first architecture.
Designed with senior data-management expertise, the platform gives sites, data managers, monitors, sponsors and biostatisticians workflows built around how they actually work. Its modern microservices, APIs and real-time data pipeline also provide the architecture for future governed AI services.
Fit the system to the study. Not the study to the system.
Replior eCOA/ePRO
Change behaviour, don’t just collect data.
Digitising a paper diary solved data capture. It did not solve motivation.
Replior’s eCOA is built around behavioural-science principles designed to sustain participation through the difficult parts of a trial. Meaningful contribution, visible progress, study-specific messaging and adaptive content reinforce why participation matters — rather than relying on reminders alone.
The results can be substantial: 99% retention at Week 28 in a long-duration dermatology study, compared with ~80% across two comparable prior studies from the same sponsor and indication, and 97% daily diary completion in a 52-week Phase III study.
Better engagement protects better data.
Wearable Sensors
Measure what patients can’t report.
Some signals are difficult to remember. Others are impossible to see.
Replior’s in-house sensors add continuous, objective measurement to the participant-reported picture.
ScratchSense captures scratching and sleep, providing objective measurement between visits where retrospective itch reporting can introduce recall bias.
RaySense measures real-world UV, visible and infrared exposure — making an environmental variable measurable rather than leaving it as uncontrolled noise.
Objective measurement. In the real world. Between visits.
See our complete platform at OCT Nordics
Measure what
patients can't report
Behavioural
science–driven.
Objective,
clinical-grade.
ScratchSense for continuous scratch and sleep measurement. RaySense for UV, visible and IR exposure.
Meet Replior in Copenhagen
Whether you’re looking to simplify study setup, improve participant retention, strengthen data quality or add objective measurement to your trial, come and talk to us at Booth 48.
Bring us your protocol, your operational challenge or simply your questions. We’d be happy to show you how Replior’s EDC, eCOA and sensor technology can fit into your study.
Visit us at Booth 48
Clarion Hotel & Congress Copenhagen Airport · Copenhagen, Denmark